E-viri
Recenzirano
Odprti dostop
-
Sanz-Muñoz, Iván; Sánchez-dePrada, Laura; Sánchez-Martínez, Javier; Rojo-Rello, Silvia; Domínguez-Gil, Marta; Hernán-García, Cristina; Fernández-Espinilla, Virginia; de Lejarazu-Leonardo, Raúl Ortiz; Castrodeza-Sanz, Javier; Eiros, José María
Emerging infectious diseases, 03/2023, Letnik: 29, Številka: 3Journal Article
Smallpox vaccination may confer cross-protection to mpox. We evaluated vaccinia virus antibodies in 162 persons ≥50 years of age in Spain; 68.5% had detectable antibodies. Highest coverage (78%) was among persons 71-80 years of age. Low antibody levels in 31.5% of this population indicates that addressing their vaccination should be a priority.
